Skip to main navigation
Skip to search
Skip to main content
Amsterdam UMC Home
Help & FAQ
Link opens in a new tab
Search content at Amsterdam UMC
Home
Researchers
Departments & Research Institutes
Projects & Funding
Publications
Datasets
Prizes
Activities
Courses
Cohorts
Press/Media
Impact
Smoking and Prevention of Thyroid Eye Disease
Wilmar M. Wiersinga
*
*
Corresponding author for this work
University of Amsterdam
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
›
Academic
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Smoking and Prevention of Thyroid Eye Disease'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Thyroid Eye Disease
100%
Current Smoking
25%
Hyaluronic Acid
25%
Serum Concentration
25%
Smoking Prevalence
25%
Tertiary Prevention
25%
Questionnaire Survey
25%
Graves' Hyperthyroidism
25%
Graves' Ophthalmopathy
25%
Non-smokers
25%
Acid Secretion
25%
Causal Relationship
25%
Tobacco Use
25%
Autoimmune
25%
Primary Prevention
25%
Muscle Volume
25%
Secondary Prevention
25%
Biological Plausibility
25%
Ophthalmopathy
25%
Current Smokers
25%
Fat Volume
25%
Orbital Fat
25%
Orbital Fibroblasts
25%
Thyrotropin Receptor Antibody (TRAb)
25%
Cigarette Smoke Extract
25%
Mature Fat Cells
25%
Medicine and Dentistry
Endocrine Ophthalmopathy
100%
Prevalence
40%
Lifespan
20%
Nicotine Withdrawal
20%
Adipocyte
20%
Fibroblast
20%
Dose Response
20%
Autoimmunity
20%
Target Cell
20%
Acid Secretion
20%
Tobacco Use
20%
Smoke
20%
Graves' Disease
20%
Tertiary Prevention
20%
Thyrotropin Receptor
20%
Drug Dose Increase
20%
Cigarette Smoke
20%
Receptor Antibody
20%
Pharmacology, Toxicology and Pharmaceutical Science
Endocrine Ophthalmopathy
100%
Prevalence
40%
Dose-Response Relationship
20%
Graves Disease
20%
Hyaluronic Acid
20%
Thyrotropin Receptor
20%
Cigarette Smoke
20%
Receptor Antibody
20%
Neuroscience
Thyroid Eye Disease
100%
Fibroblast
25%
Hyaluronic Acid
25%
Adipocyte
25%
Thyrotropin Receptor
25%
Receptor Antibody
25%